Related Experiment Video
Updated: Sep 27, 2026

Macrophage Cholesterol Depletion and Its Effect on the Phagocytosis of Cryptococcus neoformans
Published on: December 19, 2014
[Transport to an infected site of azithromycin by phagocyte cells]
1Central Research, Pfizer Pharmacenticals Inc.
Abstract:
Azithromycin is a new macrolide antibiotic developed by Pfizer. This compound has a 15 ring structure formed by adding a methyl-nitrogen to the 14-member lactone ring of erythromycin. Azithromycin has acid stability and significant improved activity against gram negative bacteria compared to other macrolides. Further, sustained high tissue levels of azithromycin have been demonstrated clinically and in basic research. There has been particular interest in the phagocyte delivery system of azithromycin to the site of infection. The mechanism is characterized by the intake of azithromycin by phagocytic cells which release the antibiotic at the site of infection. This report describes the mechanism of sustained high tissue levels by summarizing the data of Japanese and western clinical trials and research.
Insights
Azithromycin, a novel macrolide antibiotic, demonstrates enhanced activity against gram-negative bacteria and achieves sustained high tissue concentrations. Its unique phagocyte delivery system concentrates the antibiotic at infection sites for improved efficacy.
Area of Science:
- Pharmacology
- Microbiology
- Medicinal Chemistry
Context:
- Azithromycin is a semi-synthetic macrolide antibiotic derived from erythromycin.
- It exhibits improved acid stability and broader spectrum of activity, particularly against Gram-negative bacteria.
- Previous research indicated sustained high tissue levels, suggesting unique pharmacokinetic properties.
Purpose:
- To elucidate the mechanism behind sustained high tissue levels of azithromycin.
- To summarize clinical and research data on azithromycin's pharmacokinetic profile.
- To highlight the role of phagocyte-mediated delivery in azithromycin's efficacy.
Summary:
- Azithromycin, a 15-membered macrolide, possesses enhanced stability and activity compared to erythromycin.
- The antibiotic is actively taken up by phagocytic cells, which then transport it to infection sites.
- This phagocyte delivery system contributes to the prolonged and elevated concentrations of azithromycin in tissues.
Impact:
- Understanding azithromycin's tissue distribution and delivery mechanisms can optimize antibiotic therapy.
- This knowledge may lead to improved treatment strategies for bacterial infections.
- The findings support azithromycin's clinical utility due to its favorable pharmacokinetic and pharmacodynamic properties.
Related Concept Videos
Plague
Immune Surveillance by NK Cells and Phagocytes
Natural Killer Cells: The Fast Responders
NK cells are large granular lymphocytes found in the blood and lymphatic system. These...
Carrier-Mediated Transport
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
Intracellular Movement of Viruses and Bacteria
Colonisation of Pathogens
Mechanisms of Drug Absorption: Paracellular, Transcellular, and Vesicular Transport
However, most drugs use the transcellular route, traversing directly through the cell membranes via two mechanisms: passive and active transport. Passive...

